Literature DB >> 8256972

Liver transplantation as a treatment for familial amyloidotic polyneuropathy.

M Skinner1, W D Lewis, L A Jones, J Kasirsky, K Kane, S T Ju, R Jenkins, R H Falk, R W Simms, A S Cohen.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8256972     DOI： 10.7326/0003-4819-120-2-199401150-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  10 in total

Review 1.  Amyloidosis.

Authors:  M F Khan; R H Falk
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

2.  Combined cardiac and liver transplantation for the treatment of familial amyloidosis.

Authors:  Brian G Schwartz; Johannes J Kuiper; Göran B Klintmalm; Marvin J Stone; Jeffrey M Schussler
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-04

Review 3.  Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).

Authors:  Yukio Ando
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

4.  Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.

Authors:  D R Jacobson; M Ittmann; J N Buxbaum; R Wieczorek; P D Gorevic
Journal:  Tex Heart Inst J       Date:  1997

5.  Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis.

Authors:  Giampaolo Merlini; Violaine Planté-Bordeneuve; Daniel P Judge; Hartmut Schmidt; Laura Obici; Stefano Perlini; Jeff Packman; Tara Tripp; Donna R Grogan
Journal:  J Cardiovasc Transl Res       Date:  2013-10-08       Impact factor: 4.132

6.  An unusual case of cardiac amyloidosis.

Authors:  Brian Garibaldi; David Zaas
Journal:  J Gen Intern Med       Date:  2007-04-20       Impact factor: 5.128

Review 7.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

Review 8.  Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.

Authors:  Shukuro Araki; Yukio Ando
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

9.  Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity.

Authors:  Gonçalo da Costa; Ricardo A Gomes; Ana Guerreiro; Élia Mateus; Estela Monteiro; Eduardo Barroso; Ana V Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

10.  Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.

Authors:  Gabriela Molina O; Daniel Judge; Wayne Campbell; Harjit Chahal; Marc Mugmon
Journal:  J Community Hosp Intern Med Perspect       Date:  2014-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.